Guidelines in pulmonary medicine: A 25-year profile

Chest

Volumn 116, Issue 4, 1999, Pages 1046-1062

  Hackner, Dani ^a   Tu, George ^a   Weingarten, Scott ^a   Mohsenifar, Zab ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Asthma; COPD; Emphysema; Evidence based medicine; Pneumonia; Practice guideline; Pulmonary; Review; Trends

Indexed keywords

ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; EMPHYSEMA; EVIDENCE BASED MEDICINE; HUMAN; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 0032692789     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.4.1046     Document Type: Article

References (164)

1. 1 Report of the American Academy of Allergy and Immunology Task Force on Guidelines for Clinical Investigation of Nonbronchodilator Antiasthmatic Drugs. J Allergy Clin Immunol 1986; 78:489-546
2. 2 American Academy of Allergy and Immunology, American College of Allergy, and Immunology (with the Joint Council). Practice parameters for the diagnosis and treatment of asthma. J Allergy Clin 1995; 96:707-870
3. 3 Summary and recommendations of a workshop on the investigative use of fiberoptic bronchoscopy and bronchoalveolar lavage in asthmatics. Am Rev Respir Dis 1985; 132:180-182
4. 4 Drug therapy in asthma: guidelines from a group of experts [in Swedish]. Lakartidningen 1992; 89:2608-2611
5. 5 Summary and recommendations of a workshop on the investigative use of fiberoptic bronchoscopy and bronchoalveolar lavage in asthmatic patients. Chest 1985; 88:136-138
6. 6 American Thoracic Society. Guidelines for the evaluation of impairment/disability in patients with asthma. Am Rev Respir Dis 1993; 47:1056-1061
7. 7 Bergner A, Bergner RK. The international consensus report on diagnosis and treatment of asthma: a call to action for US practitioners. Clin Ther 1994; 16:694-706
8. 8 Beveridge R, Grunfeld A, Hodder R, et al. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and Canadian Thoracic Society. Guidelines for the emergency management of asthma in adults. CMAJ 1996; 155:25-37
9. 9 Guidelines for management of asthma in adults: I. Chronic persistent asthma; statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Center, National Asthma Campaign. BMJ 1990; 301:651-653
10. 10 Guidelines on the management of asthma: statement by the British Thoracic Society, the British Paediatric Association, the Research Unit of the Royal College of Physicians of London, the King's Fund Center, the National Asthma Campaign, the Royal College of General Practitioners, the General Practitioners in Asthma Group, the British Association of Accident and Emergency Medicine, and the British Paediatric Respiratory Group. Thorax 1993; 48(suppl):S1-S24
11. 11 Cartier A. Salmeterol: towards new perspectives in the treatment of asthma [in French]. Rev Mal Respir 1992; 9(Suppl 1):R31-R33
12. 12 Clinton JE, Yaron M, Tsai SH. Chest radiography in the emergency department. Ann Emerg Med 1986; 15:254-256
13. 13 Cockcroft DW. Management of acute severe asthma. Ann Allergy Asthma Immunol 1995; 75:83-89
14. 14 Eggleston PA, Rosenthal RR, Anderson SA, et al. Guidelines for the methodology of exercise challenge testing of asthmatics: Study Group on Exercise Challenge, Bronchoprovocation Committee, American Academy of Allergy. J Allergy Clin Immunol 1979; 64:642-645
15. 15 Fireman P. B2 agonists and their safety in the treatment of asthma. Allergy Proc 1995; 16:235-239
16. 16 Goldstein RA. Asthma. Ann Intern Med 1994; 121:698-708
17. 17 Kibbe DC, Kaluzny AD, McLaughlin CP. Integrating guidelines with continuous quality improvement: doing the right thing the right way to achieve the right goals. Jt Comm J Qual Improv 1994; 20:181-191
18. 18 Guidelines for the diagnosis and management of asthma: National Heart, Lung, and Blood Institute; National Asthma Education Program Expert Panel Report. J Allergy Clin Immunol 1991; 88:425-534
19. 19 North of England Asthma Guideline Development Group. North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management in adults. BMJ 1996; 312: 762-766
20. 20 National Heart, Lung, and Blood Institute, and World Health Organization. Global initiative for asthma. Bethesda, MD: National Institutes of Health, January 1995; Publication No. 95-3659
21. 21 National Heart Lung, and Blood Institute. International consensus report on diagnosis and management of asthma. Bethesda, MD: National Institutes of Health, 1992; Publication No. 92-3091
22. 22 National Asthma Education and Prevention Program. Expert panel report 2: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health, April 1997; Publication No. 97-405
23. 23 Guidelines for the management of asthma in adults in South Africa: Part 1. Chronic persistent asthma; statement by the working group of the South African Pulmonology Society. S Afr Med J 1992; 81:319-322
24. 24 Guidelines for the management of asthma in adults in South Africa: Part 2. Acute asthma; working group of the South African Pulmonology Society. S Afr Med J 1994; 84:332-338
25. 25 Management of community-acquired pneumonia in adults: working groups of the South African Pulmonology Society and the Antibiotic Study Group of South Africa. S Afr Med J 1996; 86:1152-1163
26. 26 Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 1997; 46:1-24
27. 27 Guidelines for prevention of nosocomial pneumonia: Centers For Disease Control and Prevention. Morb Mortal Wkly Rep 1997; 46:1-79
28. 28 Astin GT, Honig E, Shipp C, et al. Initial antibiotic management of community acquired pneumonia. J Med Assoc Ga 1997; 86:105-108
29. 29 Niederman MS, Bass JBJ, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148:1418-1426
30. 30 American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies: a consensus statement. Am J Respir Crit Care Med 1996; 153:1711-1725
31. 31 Barrlett JG, Breiman RF, Mandell LA, et al. Community-acquired pneumonia in adults: guidelines for management; the Infectious Diseases Society of America. Clin Infect Dis 1998; 26:811-838
32. 32 Bryan CS, Talwani R, Stinson MS. Penicillin dosing for pneumococcal pneumonia. Chest 1997; 112:1657-1664
33. 33 Gialdroni GG, Bianchi L. Guidelines for the management of community-acquired pneumonia in adults: Italian Society of Pneumology; Italian Society of Respiratory Medicine; Italian Society of Chemotherapy. Monaldi Arch Chest Dis 1995; 50:21-27
34. 34 Hoepelman IM, Sachs AP, Visser MR, et al. Anglo-Saxon guidelines for the treatment of community-acquired pneumonia applicable in The Netherlands as well [in Dutch]. Ned Tijdschr Geneeskd 1997; 141:1597-1601
35. 35 Mandell L, Niederman M. The Canadian Community Acquired Pneumonia Consensus Conference Group. Antimicrobial treatment of community acquired pneumonia in adults: a conference report. Can J Infect Dis 1993; 4:25-28
36. 36 van Kasteren ME, Wijnands WJ, Stobberingh EE, et al. Optimization of the antibiotics policy in the Netherlands: II. SWAB guidelines for the antimicrobial therapy of pneumonia in patients at home and as nosocomial infections; The Netherlands Antibiotic Policy Foundation [in Dutch]. Ned Tijdschr Geneeskd 1998; 142:952-956
37. 37 Nebulizer therapy: guidelines British Thoracic Society Nebulizer Project Group. Thorax 1997; 52(Suppl 2):S4-24
38. 38 Celli B. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152:S77-S121
39. 39 Chapman KR, Bowie DM, Goldstein RS. Canadian Thoracic Society. Workshop Group. Guidelines for the assessment and management of chronic obstructive pulmonary disease. Can Med Assoc J 1992; 147:420-428
40. 40 Chaulk CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis: consensus statement of the Public Health Tuberculosis Guidelines Panel. JAMA 1998; 279:943-948
41. 41 Caputi M, Meoli I, Manna M, et al. Proposal of a thoraco-pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease [in Italian]. Minerva Med 1997; 88:293-298
42. 42 Criner GJ, O'Brien G, Furukawa S, et al. Lung volume reduction surgery in ventilator-dependent COPD patients. Chest 1996; 110:877-884
43. 43 Fein AM, Branman SS, Casaburi R. et. al. Lung volume reduction surgery. Am J Respir Crit Care Med 1996; 154(4 Pt 1):1151-1152
44. 44 Ferguson G. Management of chronic obstructive pulmonary disease. N Engl J Med 1993; 328:1017-1022
45. 45 Grossman RF. Acute exacerbations of chronic bronchitis. Hosp Pract (Off Ed) 1992; 32:85-89
46. 46 Holohan TV, Handelsman, H. Lung-volume reduction surgery for end-stage chronic obstructive pulmonary disease. Health Technol Assess 1996; 10:1-30
47. 47 Mak H, Flynn JP, Matanoski GM. Do clinical guidelines modify the application and benefit of home oxygen? MD State Med J 1980; 29:46-49
48. 48 Pauwels RA, Lofdahl CG, Pride WB, et al. European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design. Eur Respir J 1992; 5:1254-1261
49. 49 Shayevitz MB, Shayevitz BR. Athletic training in chronic obstructive pulmonary disease. Clin Sports Med 1986; 5:471-491
50. 50 Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD): the European Respiratory Society Task Force. Eur Respir J 1995; 8:1398-1420
51. 51 Sobush DC, Dunning M. Providing resistive breathing exercise to the inspiratory muscles using the PFLEX device: suggestion from the field. Phys Ther 1986; 66:542-544
52. 52 Winterholler M, Claus D, Bockelbrink A, et al. Home ventilation in neuromuscular diseases in adults: presentation of recommendations of the Bavarian Muscle Centers of the DGM [in German]. Medizinische Klinik 1996; 91(Suppl 2):45-47
53. 53 Yusen RD, Lefrak SS. Evaluation of patients with emphysema for lung volume reduction surgery: Washington University Emphysema Surgery Group. Semin Thorac Cardiovasc Surg 1996; 8:83-93
54. 54 American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1997 57:209-218
55. 55 Fiore MC, Bailey WC, Cohen SJ, et al. Smoking Cessation Guideline Panel (Michael C. Fiore et al). Smoking cessation. In: Guide to clinical preventive services. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, April 1996; Publication No. 96-0692; 597-609
56. 56 Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. Morb Mortal Wkly Rep 1989; 38(Suppl 5):1-9
57. 57 Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. Morb Mortal Wkly Rep 1991; 40:27-32
58. 58 Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. Morb Mortal Wkly Rep 1992; 41:1-11
59. 59 Prevention and control of tuberculosis among homeless persons: recommendations of the Advisory Council for the Elimination of Tuberculosis. Morb Mortal Wkly Rep 1992; 41:13-23
60. 60 General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 1994; 43:1-38
61. 61 Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994; Centers for Disease Control and Prevention. Morb Mortal Wkly Rep 1994; 43:1-132
62. 62 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. Morb Mortal Wkly Rep 1995; 44:1-34
63. 63 Update: management of patients with suspected viral hemorrhagic fever; United States. Morb Mortal Wkly Rep 1995; 44:475-479
64. 64 Nucleic acid amplification tests for tuberculosis. Morb Mortal Wkly Rep 1996; 45:950-952
65. 65 Clinical update: impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin. Morb Mortal Wkly Rep 1996; 45:921-925
66. 66 Revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV): Centers for Disease Control and Prevention. Morb Mortal Wkly Rep 1997; 1997:46:1-29
67. 67 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: USPHS/IDSA Prevention of Opportunistic Infections Working Group. Morb Mortal Wkly Rep 1997; 46:1-46
68. 68 Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations; Centers for Disease Control and Prevention. Morb Mortal Wkly Rep 1998; 47:1-58
69. 69 Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence. Morb Mortal Wkly Rep 1993; 42:1-18
70. 70 International guidelines for the selection of lung transplant candidates: the American Society for Transplant Physicians (ASTP)/American Thoracic Society (ATS)/European Respiratory Society (ERS)/International Society for Heart and Lung Transplantation (ISHLT). Am J Respir Crit Care Med 1998; 158:335-339
71. 71 American Thoracic Society. Medical Section of the American Lung Association: the diagnosis of nonmalignant diseases related to asbestos. Am Rev Respir Dis 1986; 134:363-368
72. 72 American Thoracic Society. Medical Section of the American Lung Association: treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1986; 134:355-363
73. 73 American Thoracic Society. Chemotherapy of the pulmonary mycoses. Am Rev Respir Dis 1988; 138:1078-1081
74. 74 American Thoracic Society. Guidelines for the approach to the patient with severe hereditary alpha-1-antitrypsin deficiency. Am Rev Respir Dis 1989; 140:1494-1497
75. 75 American Thoracic Society. Medical Section of the American Lung Association: indications and standards for cardiopulmonary sleep studies. Am Rev Respir Dis 1989; 139:559-568
76. 76 American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous Mycobacteria. Am Rev Respir Dis 1990; 142:940-953
77. 77 American Thoracic Society. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis 1990; 142:725-735
78. 78 American Thoracic Society. Clinical role of bronchoalveolar lavage in adults with pulmonary disease. Am Rev Respir Dis 1990; 142:481-486
79. 79 American Thoracic Society. Environmental controls and lung disease. Am Rev Respir Dis 1990; 142:915-939
80. 80 American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144:1202-1218
81. 81 American Thoracic Society. Withholding and withdrawing life-sustaining therapy. Am Rev Respir Dis 1991; 144:726-731
82. 82 American Thoracic Society. Lung transplantation: report of the ATS workshop on lung transplantation. Am Rev Respir Dis 1993; 147:772-776
83. 83 American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994; 149:1359-1374
84. 84 American Thoracic Society. Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. [published erratum appears in Am J Respir Crit Care Med 1995; 151(2 Pt 1):578] Am J Respir Crit Care Med 1994; 150:1738-1745
85. 85 American Thoracic Society. Fungal infection in HIV-infected persons. Am J Respir Crit Care Med 1995; 152:816-822
86. 86 American Thoracic Society. Respiratory protection guidelines. Am J Respir Crit Care Med 1996; 154:1153-1165
87. 87 American Thoracic Society. Cigarette smoking and health. Am J Respir Crit Care Med 1996; 153:861-865
88. 88 American Thoracic Society Workshop. Rapid diagnostic tests for tuberculosis. Am J Respir Crit Care Med 1997; 155:1804-1814
89. 89 American Thoracic Society/European Respiratory. Pretreatment evaluation of non-small-cell lung cancer. Am J Respir Crit Care Med 1997; 156:320-332
90. 90 American Thoracic Society. Attributes of ATS documents that guide clinical practice: recommendations of the ATS Clinical Practice Committee. Am J Respir Crit Care Med 1997; 156:2015-2025
91. 91 Beal AL. Multiple organ failure syndrome in the 1990s: systemic inflammatory response and organ dysfunction. JAMA 1994; 271:226-233
92. 92 Boyle P. Cancer, cigarette smoking and premature death in Europe: a review including the recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996. Lung Cancer 1997; 17:1-60
93. 93 Council on Scientific Affairs AMA. The use of pulse oximetry during conscious sedation. JAMA 1993; 270:1463-1468
94. 94 Canadian Task Force on the Periodic Health Examination: smoking prevention and treatment. In: Canadian Guide to Clinical Preventive Health Care, 1994; 26-36, 500-511
95. 95 Cuthbertson BH, Dellinger P, Dyar OJ, et al. UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs: American-European Consensus Conference on ALI/ARDS. Intensive Care Med 1997; 23:1212-1218
96. 96 Hirsh J, Dalen JE, Deykin D, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1995; 108(4 Suppl):231S-246S
97. 97 Dooley SWJ, Castro KG, Hutton MD, et al. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. Morb Mortal Wkly Rep 1990; 39:1-29
98. 98 German Central Committee for Control of Tuberculosis. Guidelines for chemotherapy of tuberculosis. Pneumologie 1994; 48(Suppl 1):367-372
99. 99 Ginsberg JS. Management of venous thromboembolism. N Engl J Med 1996; 335:1816-1828
100. 100 Graham AA. Plethysmography: safety, effectiveness, and clinical utility in diagnosing vascular disease. Health Technol Assess 1996; 7:1-46
101. 101 Harber P, Barnhart S, Boehlecke BA, et al. Respiratory protection guidelines: this official statement of the American Thoracic Society was adopted by the ATS Board of Directors, March 1996. Am J Respir Crit Care Med 1996; 154:1153-1165
102. 102 Hirsh J, Raschke R, Warkentin TE, et al. Heparin: mechanism of action, pharmacokinetics, dosing consideration, monitoring, efficacy, and safety. Chest 1995; 108(4Suppl): 258S-275S
103. 103 Iseman MD. Treatment of multidrug-resistant tuberculosis. N Engl J Med 1993; 329:784-791
104. 104 Iseman MD, Albert R, Locks M, et al. American Thoracic Society. Medical Section of the American Lung Association; guidelines for short-course tuberculosis chemotherapy. Am Rev Respir Dis 1980; 121:611-614
105. 105 Joint Committee on Smoking and Health. Physician responsibility: a statement of the Joint Committee on Smoking and Health. Chest 1995; 108:1118-1121
106. 106 Masur H. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex. N Engl J Med 1993; 329:898-904
107. 107 Meyer TJ, Hill NS. Noninvasive positive pressure ventilation to treat respiratory failure. Ann Intern Med 1994; 120:760-770
108. 108 Miller AC, Harvey JE. Guidelines for the management of spontaneous pneumothorax: Standards of Care Committee, British Thoracic Society. BMJ 1993; 307:114-116
109. 109 O'Donohue WJJ, Giovannoni RM, Goldberg AI, et al. Long-term mechanical ventilation: guidelines for management in the home and at alternate community sites; report of the Ad Hoc Committee, Respiratory Care Section, American College of Chest Physicians. Chest 1986; 90:1S-37S
110. 110 Rosenberg E. The update of recommendations for a standard technique for measuring the single-breath carbon monoxide diffusing capacity (transfer factor). [corrected and republished in Am J Respir Crit Care Med 1996; 154(3 Pt 1):827-828] Am J Respir Crit Care Med 1996; 154:265-266
111. 111 Rosenberg E. The update of recommendations for a standard technique for measuring the single-breath carbon monoxide diffusing capacity (transfer factor). Am J Respir Crit Care Med 1996; 1995; 154:265-266
112. 112 Stogmann W, Junker E. Guidelines for tuberculin diagnosis: consensus paper of the Austrian Society of Lung Diseases and Tuberculosis [in German]. Wiener Medizinische Wochenschrift 1994; 144:163-167
113. 113 US Preventive Services Task Force. Counseling to prevent tobacco use: guide to clinical preventive services. Baltimore, MD: Williams & Wilkins, 1996; 597-609
114. 114 Van Gundy K, Boylen CT. Fiberoptic bronchoscopy: indications, complications, contraindications. Postgrad Med 1988; 83:289-294
115. 115 Woolf SH, Jonas S, Lawrence RS. Tobacco use: counseling and adjunctive treatment. In: Manley M, ed. Health promotion and disease prevention in clinical practice. Baltimore, MD: Williams & Wilkins, 1996; 163-175
116. 116 Abramson MJ, Puy RM, Weiner JM. Allergen specific immunotherapy in asthma. Cochrane Database of Systematic Reviews 1999. Available at gateway.ovid.com. Accessed August 9, 1999
117. 117 Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study. JAMA 1994; 272:1497-1505
118. 118 Bernstein DI, Cohen R, Ginchansky E, et al. A multicenter, placebo-controlled study of twice daily triamcinolone acetonide (800 microg per day) for the treatment of patients with mild-to-moderate asthma. J Allergy Clin Immunol 1998; 101:433-438
119. 119 Camargo C, Rowe B, Jones A, et al. A comparison of continuous vs. intermittent beta-agonists in the treatment of acute asthma in the emergency department. Cochrane Database of Systematic Reviews 1999. Available at gateway. ovid.com. Accessed August 9, 1999
120. 120 Cates C, Ducharme F, Gipson P, et al. Comparison of holding chambers and nebulisers for beta-agonists in the treatment of acute asthma. Cochrane Database of Systematic Reviews 1999. Available at gateway.ovid.com. Accessed August 9, 1999
121. 121 Cook D, De Jonghe B, Brochard L, et al. Influence of airway management on ventilator-associated pneumonia: evidence from randomized trials. JAMA 1998; 279:781-787
122. 122 D'Amico R, Pifferi S, Leonetti C, et al. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ 1998; 316:1275-1285
123. 123 Fabian TC, Boucher BA, Croce MA, et al. Pneumonia and stress ulceration in severely injured patients: a prospective evaluation of the effects of stress ulcer prophylaxis. Arch Surg 1993; 128:185-191
124. 124 Feder G, Griffiths C, Highton C, et al. Do clinical guidelines introduced with practice based education improve care of asthmatic and diabetic patients? A randomised controlled trial in general practices in east London, BMJ 1995; 311: 1473-1478
125. 125 Gibson PG, Coughlan J, Wilson AJ, et al. The effects of limited (information only) patient education programs on the health outcomes of adults with asthma. Cochrane Database of Systematic Reviews 1999. Available at gateway.ovid. com. Accessed August 8, 1999
126. 126 Grampian Asthma Study of Integrated Care (GRASSIC). Effectiveness of routine self monitoring of peak flow in patients with asthma. BMJ 1994; 308:564-567
127. 127 Greening AP, Ind PW, Northfield M, et al. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid: Allen & Hanburys Limited UK Study Group. Lancet 1994; 344:219-224
128. 128 Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993; 342:1317-1322
129. 129 Handoll HHG, Farrar MJ, McBirnie J, et al. Prophylaxis using heparin, low molecular weight heparin and physical methods against deep vein thrombosis and pulmonary embolism in hip fracture surgery. Cochrane Database of Systematic Reviews 1999. Available at gateway.ovid.com. Accessed August 8, 1999
130. 130 Karuza J, Calkins E, Feather J, et al. Enhancing physician adoption of practice guidelines: dissemination of influenza vaccination guideline using a small-group consensus process. Arch Intern Med 1995; 155:625-632
131. 131 Linde K, Jobst KA. Homeopathy for chronic asthma. Cochrane Database of Systematic Reviews 1999. Available at gateway.ovid.com. Accessed August 8, 1999
132. 132 Mahon J, Laupacis A, Donner A, et al. Randomised study of n of 1 trials versus standard practice. BMJ 1996; 312:1069-1074
133. 133 McConnell TS, Cushing AH, Bankhurst AD, et al. Physician behavior modification using claims data: tetracycline for upper respiratory infection. West J Med 1982; 137:448-450
134. 134 Plaisance P, Adnet F, Vicaut E, et al. Benefit of active compression-decompression cardiopulmonary resuscitation as a prehospital advanced cardiac life support: a randomized multicenter study. Circulation 1997; 95:955-961
135. 135 Raschke RA, Reilly BM, Guidry JR, et al. The weight-based heparin dosing nomogram compared with a "standard care" nomogram: a randomized controlled trial. Ann Intern Med 1993; 119:874-881
136. 136 Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 1998; 316:961-964
137. 137 Sommaruga M, Spanevello A, Migliori GB, et al. The effects of a cognitive behavioral intervention in asthmatic patients. Monaldi Arch Chest Dis 1995; 50:398-402
138. 138 Lancaster T. Individual behavioral counseling for smoking cessation. Cochrane Database of Systematic Reviews 1999. Available at gateway.ovid.com. Accessed August 8, 1999
139. 139 Strange C, Vaughan L, Franklin C, et al. Comparison of train-of-four and best clinical assessment during continuous paralysis. Am J Respir Crit Care Med 1997; 156:1556-1561
140. 140 Thomason M, Payseur E, Hakenewerth A, et al. Nosocomial pneumonia in ventilated trauma patients during stress ulcer prophylaxis with sucralfate, antacid, and ranitidine. J Trauma 1996; 41:503-508
141. 141 Tryba M. Prophylaxis of upper gastrointestinal bleeding in intensive care units: a meta-analysis. Crit Care Med 1990; 18:1491-1493
142. 142 van der Molen T, Meyboom-de JB, Mulder HH, et al. Starting with a higher dose of inhaled corticosteroids in primary care asthma treatment. Am J Respir Crit Care Med 1998; 158:121-125
143. 143 Volmink J, Garner P. Systematic review of randomised controlled trials of strategics to promote adherence to tuberculosis treatment. BMJ 1997; 315:1403-1406
144. 144 Weingarten SR, Riedinger MS, Hobson P, et al. Evaluation of a pneumonia practice guideline in an interventional trial. Am J Respir Crit Care Med 1996; 153:1110-1115
145. 145 Wilson SR, Scamagas P, German DF, et al. A controlled trial of two forms of self-management education for adults with asthma. Am J Med 1993; 94:564-576
146. 146 Spelman R. Recent asthma guidelines: what are the implications for patient management? Ir Med J 1993; 86:165-167
147. 147 Habbick B, Baker MJ, McNutt M, et al. Recent trends in the use of inhaled beta 2-adrenergic agonists and inhaled corticosteroids in Saskatchewan. CMAJ 1995; 153:1437-1443
148. 148 Bernstein DI, Cohen R, Ginchansky E, et al. A multicenter, placebo-controlled study of twice daily triamcinolone acetonide (800 microg per day) for the treatment of patients with mild-to-moderate asthma. J Allergy Clin Immunol 1998; 101:433-438
149. 149 Haahtela T, Jarvinen M, Kava T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994; 331:700-705
150. 150 Gordon G, Throop D, Berberian L, et al. Validation of the American Thoracic Society guidelines for community acquired pneumonia in hospitalized patients [abstract]. Am Rev Respir Crit Care Med 1996; 153A:257
151. 151 Neill AM, Martin IR, Weir R, et al. Community acquired pneumonia: etiology and usefulness of severity criteria on admission. Thorax 1996; 51:1010-1016
152. 152 Leroy O, Georges H, Beuscart C, et al. Severe community-acquired pneumonia in ICUs: prospective validation of a prognostic score. Intensive Care Med 1996; 22:1307-1314
153. 153 Fine M, Auble TE, Yealy Dm. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336:243-250
154. 154 Utz JP, Hubmayr RD, Deschamps C. Lung volume reduction surgery for emphysema: out on a limb without a NETT. Mayo Clin Proc 1998; 73:552-566
155. 155 Naylor CD, Sibbald WJ, Sprung CL, et al. Pulmonary artery catheterization: can there be an integrated strategy for guideline development and research promotion? JAMA 1993; 269:2407-2411
156. 156 Bailey R, Weingarten S, Lewis M, et al. Impact of clinical pathways and practice guidelines on the management of acute exacerbations of bronchial asthma. Chest 1998; 113: 28-33
157. 157 Hyams AL, Brandenburg JA, Lipsitz SR. Practice guidelines and malpractice litigation: a two-way street. Ann Intern Med 1995; 122:450-455
158. 158 Bartlett EE. Practice guidelines and malpractice litigation [letter]. Ann Intern Med 1995; 123:556
159. 159 Noble A, Brennan TA, Hyams AL, et al. American Association of Blood Banks: a re-examination of liability for medical practice guideline promulgators. J Eval Clin Pract 1998; 4:49-62
160. 160 Skolnick AA. JCAHO, NCQA, and AMAP establish council to coordinate health care performance measurement: Joint Commission on Accreditation of Healthcare Organizations; National Committee for Quality Assurance, American Medical Accreditation Program. JAMA 1998; 279:1769-1770
161. 161 Cromwell J, Bartosch WJ, Fiore MC, et al. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation: Agency for Health Care Policy and Research. JAMA 1997; 278:1759-1766
162. 162 McGowan JE Jr. Success, failures and costs of implementing standards in the USA: lessons for infection control. J Hosp Infect 1995; 30(Suppl):76-87
163. 163 Rhew DC, Riedinger MS, Sandhu M, et al. A prospective, multicenter study of a pneumonia practice guideline. Chest 1998; 114:115-119
164. 164 Weingarten S. Practice guidelines and prediction rules should be subject to careful clinical testing. JAMA 1997; 277:1977-1978